Investigational Treatment for ADPKD Earns FDA’s Orphan Drug Designation
source: pixabay.com

Investigational Treatment for ADPKD Earns FDA’s Orphan Drug Designation

Approximately 540,000 individuals in the United States have been diagnosed with autosomal dominant polycystic kidney disease (ADPKD). The disease causes persistent and rapidly accumulating cysts to grow in the patient’s…

Continue Reading Investigational Treatment for ADPKD Earns FDA’s Orphan Drug Designation
Is the CDC Botching its RSV Vaccine Rollout?
source: shutterstock.com

Is the CDC Botching its RSV Vaccine Rollout?

  • Post author:
  • Post category:RSV

Last fall, a new vaccine for respiratory syncytial virus (RSV) intended for pregnant people was made available to the public. Physician Sarah Turner, who was used to getting some pushback…

Continue Reading Is the CDC Botching its RSV Vaccine Rollout?
Rare Community Profiles: How a Clinical Study Changed Dana’s Trajectory After Desmoid Tumor Recurrence
source: pixabay.com

Rare Community Profiles: How a Clinical Study Changed Dana’s Trajectory After Desmoid Tumor Recurrence

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: How a Clinical Study Changed Dana’s Trajectory After Desmoid Tumor Recurrence